325 related articles for article (PubMed ID: 31647102)
1. Characterization and repurposing of the endogenous Type I-F CRISPR-Cas system of Zymomonas mobilis for genome engineering.
Zheng Y; Han J; Wang B; Hu X; Li R; Shen W; Ma X; Ma L; Yi L; Yang S; Peng W
Nucleic Acids Res; 2019 Dec; 47(21):11461-11475. PubMed ID: 31647102
[TBL] [Abstract][Full Text] [Related]
2. Establishment and application of a CRISPR-Cas12a assisted genome-editing system in Zymomonas mobilis.
Shen W; Zhang J; Geng B; Qiu M; Hu M; Yang Q; Bao W; Xiao Y; Zheng Y; Peng W; Zhang G; Ma L; Yang S
Microb Cell Fact; 2019 Oct; 18(1):162. PubMed ID: 31581942
[TBL] [Abstract][Full Text] [Related]
3. Development of a counterselectable system for rapid and efficient CRISPR-based genome engineering in Zymomonas mobilis.
Zheng Y; Fu H; Chen J; Li J; Bian Y; Hu P; Lei L; Liu Y; Yang J; Peng W
Microb Cell Fact; 2023 Oct; 22(1):208. PubMed ID: 37833755
[TBL] [Abstract][Full Text] [Related]
4. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
[TBL] [Abstract][Full Text] [Related]
5. Elimination of editing plasmid mediated by theophylline riboswitch in Zymomonas mobilis.
Huang Y; Chen M; Hu G; Wu B; He M
Appl Microbiol Biotechnol; 2023 Dec; 107(23):7151-7163. PubMed ID: 37728624
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-mediated host genomic DNA damage is efficiently repaired through microhomology-mediated end joining in Zymomonas mobilis.
Wang X; Wu B; Sui X; Zhang Z; Liu T; Li Y; Hu G; He M; Peng N
J Genet Genomics; 2021 Feb; 48(2):115-122. PubMed ID: 33958317
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
8. Improving Mobilization of Foreign DNA into Zymomonas mobilis Strain ZM4 by Removal of Multiple Restriction Systems.
Lal PB; Wells F; Myers KS; Banerjee R; Guss AM; Kiley PJ
Appl Environ Microbiol; 2021 Sep; 87(19):e0080821. PubMed ID: 34288704
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a transient CRISPR-Cas9 genome editing system in Candida glycerinogenes for co-production of ethanol and xylonic acid.
Zhu M; Sun L; Lu X; Zong H; Zhuge B
J Biosci Bioeng; 2019 Sep; 128(3):283-289. PubMed ID: 30967334
[TBL] [Abstract][Full Text] [Related]
10. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas-based genome engineering in natural product discovery.
Tong Y; Weber T; Lee SY
Nat Prod Rep; 2019 Sep; 36(9):1262-1280. PubMed ID: 30548045
[TBL] [Abstract][Full Text] [Related]
12. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
[TBL] [Abstract][Full Text] [Related]
13. Endogenous CRISPR-assisted microhomology-mediated end joining enables rapid genome editing in Zymomonas mobilis.
Sui X; Wang X; Liu T; Ye Q; Wu B; Hu G; Yang S; He M; Peng N
Biotechnol Biofuels; 2021 Oct; 14(1):208. PubMed ID: 34689795
[TBL] [Abstract][Full Text] [Related]
14. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
[TBL] [Abstract][Full Text] [Related]
15. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production.
Li H; Shen CR; Huang CH; Sung LY; Wu MY; Hu YC
Metab Eng; 2016 Nov; 38():293-302. PubMed ID: 27693320
[TBL] [Abstract][Full Text] [Related]
17. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
18. Repurposing the Endogenous Type I-E CRISPR/Cas System for Gene Repression in
Qin Z; Yang Y; Yu S; Liu L; Chen Y; Chen J; Zhou J
ACS Synth Biol; 2021 Jan; 10(1):84-93. PubMed ID: 33399467
[No Abstract] [Full Text] [Related]
19. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
20. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum.
Wasels F; Jean-Marie J; Collas F; López-Contreras AM; Lopes Ferreira N
J Microbiol Methods; 2017 Sep; 140():5-11. PubMed ID: 28610973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
